Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders
- 15 November 2011
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 42 (1) , 16-25
Abstract
It has been shown that many hereditary motor neuron diseases are caused by mutation of RNA processing enzymes. Survival of motor neuron 1 (SMN1) is well-known as a causative gene for spinal muscular atrophy (SMA) and mutations of glycyl- and tyrosyl-tRNA synthetases are identified as a cause of distal SMA and Charcot–Marie–Tooth disease. Why and how the dysfunction of these ubiquitously expressed genes involved in RNA processing can cause a specific neurological disorder is not well understood. Interestingly, SMN complex has been identified recently as a new target of autoantibodies in polymyositis (PM). Autoantibodies in systemic rheumatic diseases are clinically useful biomarkers associated with a particular diagnosis, subset of a disease, or certain clinical characteristics. Many autoantibodies produced in patients with polymyositis/dermatomyositis (PM/DM) target RNA–protein complexes such as aminoacyl tRNA synthetases. It is interesting to note these same RNA–protein complexes recognized by autoantibodies in PM/DM are also responsible for genetic neuromuscular disease. Certain RNA–protein complexes are also targets of autoantibodies in paraneoplastic neurological disorders. Thus, there are several interesting associations between RNA-processing enzymes and neuromuscular disorders. Although pathogenetic roles of autoantibodies to intracellular antigens are generally considered unlikely, understanding the mechanisms of antigen selection in a particular disease and specific neurological symptoms caused by disruption of ubiquitous RNA-processing enzyme may help identify a common path in genetic neuromuscular disorders and autoimmunity in inflammatory myopathies.Keywords
This publication has 63 references indexed in Scilit:
- Understanding the role of TDP-43 and FUS/TLS in ALS and beyondCurrent Opinion in Neurobiology, 2011
- Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteinsArthritis & Rheumatism, 2011
- An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutationsMolecular and Cellular Neuroscience, 2011
- Mutation of the Mitochondrial Tyrosyl-tRNA Synthetase Gene, YARS2, Causes Myopathy, Lactic Acidosis, and Sideroblastic Anemia—MLASA SyndromeThe American Journal of Human Genetics, 2010
- RNA processing defects associated with diseases of the motor neuronMuscle & Nerve, 2009
- A systematic review of humoral immune responses against tumor antigensCancer Immunology, Immunotherapy, 2009
- Sarcoplasmic redistribution of nuclear TDP‐43 in inclusion body myositisMuscle & Nerve, 2009
- Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseasesModern Rheumatology, 2009
- Rethinking ALS: The FUS about TDP-43Cell, 2009
- Clinical and serological features of patients with autoantibodies to GW/P bodiesClinical Immunology, 2007